Antogen
A biotechnology company translating immunopeptidomics into clinically actionable results through innovative research tools and diagnostics designed to improve patient outcomes.
Executive Brief
By combining advanced proteomics, Human Leukocyte Antigen (HLA) biology, machine learning, and proprietary biological datasets, the company is building platforms that reveal meaningful immune signals and translate them into clinically actionable insights.
The company is led by an experienced team of life sciences innovators with a proven track record in diagnostics, translational research, and commercial execution.
Antogen is advancing the next generation of precision diagnostics and therapeutic discovery through the identification and analysis of HLA ligands directly from biological samples, supporting discovery programs, translational studies in oncology, immunotherapy development, and autoimmune disease research.
Founder(s) Zachary Antovich
Stage Venture
Location Greece, USA
Biotechnology & Life Sciences